UK Research and Innovation (UKRI) and FAPESP’s lead agency agreement allows UKRI to assess joint applications from eligible UK and Brazil-based researchers from the state of São Paulo on behalf of both organisations.
UKRI and FAPESP will co-fund applications submitted to responsive mode funding opportunities via selected funding opportunities.
UKRI and FNR have signed a memorandum of understanding to enable and support applications between researchers in the UK and Luxembourg. UKRI will fund the UK component and FNR will fund the Luxembourg component of the application.
Conditions will differ depending on the funding opportunity.
UKRI and Research Council of Norway have signed a Money Follows Cooperation agreement to enable collaborative applications between researchers in the UK and Norway. UKRI funding will be provided for project co-leads based in Norway in successful applications. Applications must be submitted through existing council programmes.
Apply for funding to run a high throughput screen (HTS) using AstraZeneca’s compound library and screening robots.
Two funding opportunities per year with changing highlights. This funding opportunity will have a highlight on new targets related to pain or women’s health (including conditions related to metabolic disorders).
Apply for funding for breakthrough or disruptive interdisciplinary ideas that transcend, combine or significantly span disciplines that are not routinely funded through existing UK Research and Innovation (UKRI) responsive mode schemes.
Project leads must be based at an organisation eligible for UKRI research council funding.
Apply for funding to investigate the causes, progression and treatment of human disease.
Your application must include an intervention in humans.
You must be a researcher based at a research organisation eligible to apply for MRC funding. Researchers transitioning to independence may be eligible to apply as a ‘new investigator’.
Apply for funding to support a new research partnership to enable the development and delivery of novel research that will address global health challenges and inequities.
You must be invited to apply for stage two of this funding.